CI&T Inc Q2 2026 Earnings Call Summary

CI&T Inc reported Q2 2026 results and said record revenue growth reflects a shift to AI deployments and value-based pricing. Adjusted gross margin rose to 32.4%. Full-year revenue guidance was raised to $566 million to $578 million, with adjusted EBITDA margin at 15% to 17% amid FX headwinds and planned AI investments.

Original reporting
Published Aug 13, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CI&T Inc Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

Med
01

Why it matters

The key tradable inputs are the raised revenue guidance ($566M-$578M), revised adjusted EBITDA margin guidance (15%-17%), and the stated drivers (FX headwinds, discretionary Agentic SDLC spending, and expected sequential margin improvement in 2H 2026).

02

Market read

Traders can update CI&T’s growth and margin expectations using the call’s explicit guidance revisions and investment/FX explanations.

03

What to watch

The article notes token-cost declines but higher token usage; if usage growth slows, consumption-based pricing could still deflate revenue despite model capability gains.

Relevance 8/10Novelty 7/10Timing: today, during/after the Q2 2026 earnings call

Background

CI&T management described a transition year focused on AI deployment, value-based pricing, and an Agentic Enterprise framework tied to Agentic SDLC engagements.

Market effects

Reinforces demand shift toward AI deployment and value-based pricing in IT services, with agentic SDLC work supporting higher-margin mix.

Highlights Latin America as the primary growth engine (32.1% YoY), suggesting regional demand strength despite FX volatility.

Partnership framing with Anthropic and Mistral signals continued enterprise adoption of frontier models under compliance constraints.

Counterpoint

Raised revenue guidance may be partially offset by FX and transitional investment spend, so margin recovery could lag if pipeline conversion or repricing takes longer than 18 months.

Key entities

  • CI&T

    IT services provider discussing AI deployment shift, value-based pricing, Agentic SDLC investments, and updated 2026 guidance.

  • Anthropic

    Named strategic partnership for deploying frontier models in regulated enterprise environments.

  • Mistral

    Named strategic partnership for deploying frontier models in regulated enterprise environments.

Related articles

$CINTMed

CI&T Inc (CINT) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven

CI&T Inc (CINT) reported Q3 2026 revenue growth of 14.9% YoY, but adjusted EBITDA declined 3.9% due to FX and payroll tax headwinds. Q4 guidance is $142.3M-$152.0M, with deceleration due to macro uncertainty. Gross margin expanded sequentially due to AI-driven productivity and value-based models, but organic growth slowed. The pipeline is up 50% YoY, with 70% from existing clients. AI partnerships and value-based models are expected to drive 2027 growth.

$CINTLow

What CI&T (CINT) Said on Its Q3 Earnings Call

CI&T (CINT) reported Q3 adjusted EBITDA fell 3.9% YoY due to currency effects, but rose 3.4% on a currency-neutral basis to $24.3M. Revenue from non-top-10 clients grew 17.1% YoY, outpacing top clients' 12.2% growth. Adjusted profit increased 2% to $11.5M. The company forecasted Q4 revenue of $142.3M-$152.0M and raised its 2026 revenue outlook to $568M-$578M.

$CINTMedAI 8/10

CI&T (CINT) Q2 2026 Earnings Call Transcript

CI&T (CINT) reported Q2 2026 revenue of $142.8M, up 21.9% YoY, exceeding guidance. Full-year revenue guidance raised to $566M-$578M. Adjusted EBITDA was $19M with a 13.3% margin. Sales pipeline expanded 40% YoY, driven by AI demand. Financial services and tech/telecom verticals grew 36% and 68% YoY, respectively. Consumer goods revenue declined 9% YoY. Management highlighted investments in AI and value-based pricing models.

$SGPMedAI 8/10

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

SpyGlass Pharma, Inc. (SGP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates • Acquired Advanced Vision Science, Inc. (AVS), securing scalable commercial intraocular lens (IOL) manufacturing capacity for its Phase 3 lead product candidate the Bimatopro

$ONDSHighAI 8/10

Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook

Ondas Inc. (ONDS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook Record Q3 revenue of $167.5 million, up 100% sequentially and more than 16-fold year over year; pro forma organic revenue grew 64% year-over-year Capt